A Reform Council Just Threatened to Ban HMOs Across an Entire Borough

Newcastle-under-Lyme: The Borough That Could Go Dark for HMO Investors

On 14 July 2026, Landlord Today reported that Reform UK-controlled Newcastle-under-Lyme is actively investigating a borough-wide Article 4 Direction that would require planning permission for any new HMO conversion across the entire borough. Not a targeted zone. Not a student corridor. The whole borough.

That's a significant escalation. Most councils that introduce Article 4 Directions apply them to specific wards or postcodes where HMO density is already high. Newcastle-under-Lyme appears to be considering a blanket approach — which, if confirmed, would make it one of the most restrictive HMO regimes in England.

I want to be clear about what 'investigating' means in planning terms. It doesn't mean it's done. Article 4 Directions require a formal consultation period and, under the Town and Country Planning (General Permitted Development) (England) Order 2015, councils must give at least 12 months' notice before removing permitted development rights — unless they invoke an 'immediate' Direction under certain urgency provisions. So there's a window. But it's closing.

This Isn't One Rogue Council — It's a Wave

Newcastle-under-Lyme didn't arrive in a vacuum. The research notes for this piece tell a clear story: Tameside implemented an immediate Article 4 Direction in late 2025. Warrington approved borough-wide controls and published a Supplementary Planning Document on top. Luton introduced selective licensing mid-2026.

And according to Property Reporter (2 July 2026), citing Saif Derzi of Property Buyers Today, there are now 472,823 HMOs in England — up 2.3% year-on-year. Supply is still growing. But the planning environment is tightening around it.

This is the tension every serious HMO investor needs to sit with: the market is expanding, but the geography of where you can legally create a new HMO is shrinking. That's not a contradiction. That's the investment thesis.

Tameside's 'immediate' Direction is worth dwelling on. When a council bypasses the standard 12-month notice and moves directly to enforcement, it signals that the political will is strong enough to absorb the legal challenge risk. Reform UK taking the same posture in Newcastle-under-Lyme — a party that campaigned partly on housing supply — is an interesting political wrinkle. Whether you read it as anti-landlord or pro-community-character depends on your priors. What it means operationally is the same either way: the window to convert in that borough is narrowing fast.

What Article 4 Actually Does to Your Investment Math

Here's the mechanism that most commentary misses: Article 4 Directions don't just restrict new supply. They increase the value of existing, compliant, licensed HMOs in the affected area.

Think about it from first principles. If planning permission for new HMO conversions becomes difficult or impossible to obtain, the stock of licensed HMOs in that borough becomes a finite, protected pool. Demand from tenants doesn't disappear — in fact, it typically rises in areas with strong employment or universities, which is exactly the profile of many Article 4 target zones. Fewer new units chasing the same or growing demand means yield compression reverses for existing operators.

I've seen this play out in cities that implemented Article 4 years ago. Existing HMO landlords in those areas who held their nerve and maintained compliance saw their properties become significantly harder to replicate. That's a moat.

The trade-off — and I'll name it directly — is that buying a compliant HMO inside an Article 4 zone now costs more upfront. The scarcity premium is already being priced in by vendors who understand the regulatory shift. You're not getting a bargain. You're buying a defensible asset at a fair price, which is a different thing.

For investors still hunting pre-Article 4 opportunities in areas not yet restricted, the clock is the variable. Newcastle-under-Lyme is in investigation phase. That's not a Direction yet. The question is whether you can identify, finance, and complete before the Direction lands.

Where to Look Now: The Article 4 Opportunity Map

My read on the current map is this: the highest-risk zones for new conversions are councils with high student populations, high HMO density relative to total housing stock, and political administrations — of any party — that have faced sustained resident pressure on housing character. Newcastle-under-Lyme ticks multiple boxes.

The opportunity zones are the inverse: areas with strong rental demand fundamentals, lower current HMO density, and councils that have not yet signalled Article 4 intent. These areas still allow conversion under permitted development rights, meaning you can move from purchase to operational HMO without a planning battle.

I'm not going to pretend I can tell you which specific postcodes to target in a single article — the data changes weekly and the intelligence required is granular. What I can tell you is that mapping Article 4 status across every English council is the single most important desk-research step before committing to any HMO acquisition in 2026.

This is exactly why a database that tracks HMO stock at scale matters. ZARSK's database — which I'd argue is the largest live HMO database in the UK — lets you cross-reference where licensed HMOs currently exist against areas where Article 4 has or hasn't landed. That's not a marketing line. That's the practical research workflow for any investor trying to avoid buying into a borough that's about to go dark.

The Financing Problem Nobody Talks About Loudly Enough

Even if you identify the right area and the right property, you still have to fund it. And this is where a lot of otherwise smart investors stall.

HMO mortgages are a specialist product. High-street lenders largely don't touch them. The criteria — minimum room counts, licensing status, Article 4 compliance, rental income calculations based on room-by-room projections rather than single AST — require lenders who understand the asset class. For first-time HMO investors, getting a mortgage offer at all can feel like the hardest part of the deal.

For existing portfolio holders, the problem is different but equally frustrating. Equity locked inside a buy-to-let or HMO portfolio is dead money unless you can refinance it out. Stress tests, portfolio underwriting, and the way lenders calculate background portfolio income have all tightened since 2022. I've spoken to landlords with genuinely strong portfolios who couldn't release equity through their existing broker relationships because those brokers didn't have the specialist lender access.

This is why the finance piece of any HMO strategy needs specialist input, not generalist mortgage broking. ZARSK's regulated finance partners work specifically in this space — HMO mortgages, portfolio refinancing, equity release from existing property assets. If you're sitting on equity you can't access, or you're trying to finance your first HMO acquisition and hitting walls, that's the conversation worth having. You can explore the finance options at [zarsk.co.uk/finance-property](https://www.zarsk.co.uk/finance-property).

What I'd Do If I Were Buying an HMO This Month

First: I'd treat Article 4 status as a primary filter, not an afterthought. Before I looked at yield, condition, or price, I'd want to know whether that borough has a Direction in force, one in consultation, or one under investigation. Those are three materially different risk profiles.

Second: I'd look at areas adjacent to Article 4 zones. Tenant demand doesn't respect council boundaries. If the borough next door has clamped down, demand spills over — and if the adjacent area hasn't yet moved, you may still be able to convert under permitted development.

Third: I'd get my finance arranged before I started viewing. HMO mortgage offers take longer than standard buy-to-let offers. If you're competing against a cash buyer or a well-financed operator, showing up with a mortgage in principle from a specialist lender is the difference between winning and losing a deal.

Fourth: I'd stop treating compliance as a cost and start treating it as a competitive advantage. The operators who will dominate HMO markets in Article 4 zones over the next five years are the ones who have clean licensing, proper fire safety, and documented management standards. That's the profile that retains good tenants, commands premium rents, and survives council inspections.

The 472,823 HMOs currently in England (Property Reporter, 2 July 2026) represent a market that is still growing. But the distribution of where that growth is possible is shifting rapidly. The investors who map that shift now are the ones who'll still be acquiring in 2027.

Article 4 is being framed in some quarters as the death of HMO investing. That framing is wrong, and I think it's being pushed by people who either don't understand the scarcity mechanism or who want to create panic. The real story is a bifurcation: the amateur, unplanned, compliance-light end of the market gets squeezed out; the professional, data-driven, well-financed operator gets a cleaner competitive field. Newcastle-under-Lyme's investigation is five days old. The Direction isn't confirmed. But the direction of travel — if you'll excuse the wordplay — has been clear for at least 18 months. The councils that haven't moved yet are the opportunity. The ones that have moved are the proof of concept. Decide which side of that line you want to be on before someone else decides for you.